The role of PTEN and TP53 co-mutations in immunotherapy of lung cancer.

被引：0
|
作者：
Ma, Xiaolong
Zhang, Ding
Chen, Shiqing
机构：
[1] First Hosp Jiaxing, Dept Resp Med, Jiaxing, Peoples R China
[2] 3D Med Inc, Med Dept, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e21161
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21161
引用
收藏
页数：3
相关论文
共 50 条
  • [21] TP53 Co-Mutations in Advanced EGFR-Mutated Non-Small Cell Lung Cancer: Prognosis and Therapeutic Strategy for Cancer Therapy
    Liu, Surui
    Yu, Jin
    Zhang, Hui
    Liu, Jie
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [22] TP53 and mutations in human cancer
    Szymanska, K
    Hainaut, P
    [J]. ACTA BIOCHIMICA POLONICA, 2003, 50 (01) : 231 - 238
  • [23] Characteristics and prognosis of rrDLBCL with TP53 mutations and a high-risk subgroup represented by the co-mutations of DDX3X-TP53
    Gao, Fan
    Hu, Kai
    Zheng, Peihao
    Shi, Hui
    Ke, Xiaoyan
    [J]. CANCER MEDICINE, 2023, 12 (09): : 10267 - 10279
  • [24] Smoking, lung cancers and their TP53 mutations
    Cooper, CS
    [J]. MUTAGENESIS, 2002, 17 (04) : 279 - 280
  • [25] Novel immunotherapy strategies targeting PTEN and TP53 defects in advanced prostate cancer
    Shi, Wei
    Wang, Yin
    Zhao, Yuehui
    Zhao, Di
    [J]. CANCER RESEARCH, 2023, 83 (11)
  • [26] Effect of TP53 mutation on antitumor immunity and responsiveness to immunotherapy in colorectal cancer.
    Lu, Zhihao
    Shen, Lin
    Zhang, Henghui
    Jiao, Xi
    Wang, Yujiao
    Chen, Huan
    Han, Wenbo
    Liu, Chang
    Gong, Jifang
    Li, Jian
    Zhang, Xiaotian
    Wang, Xicheng
    Peng, Zhi
    Qi, Changsong
    Wang, Zhenghang
    Li, Yanyan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [27] Role of TP53 Mutations in Vulvar Carcinomas
    Choschzick, Matthias
    Hantaredja, Widianto
    Tennstedt, Pierre
    Gieseking, Frederike
    Woelber, Linn
    Simon, Ronald
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2011, 30 (05) : 497 - 504
  • [28] Prognostic Effect of TP53 and PKD Co-Mutations in Patients with Resected Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma
    Di-Han Liu
    Ze-Rui Zhao
    Yao-Bin Lin
    Wen-Jie Zhou
    Jing-Yu Hou
    Zheng-Hao Ye
    Hao Long
    [J]. Annals of Surgical Oncology, 2019, 26 : 1934 - 1941
  • [29] Prognostic Effect of TP53 and PKD Co-Mutations in Patients with Resected Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma
    Liu, Di-Han
    Zhao, Ze-Rui
    Lin, Yao-Bin
    Zhou, Wen-Jie
    Hou, Jing-Yu
    Ye, Zheng-Hao
    Long, Hao
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (06) : 1934 - 1941
  • [30] TP53 haplotypes and susceptibility to breast cancer.
    Kristensen, Vessela
    Garcia-Closas, Montserrat
    Langerod, Anita
    Qi, Ying
    Yeager, Meredith
    Burdett, Laurie
    Welch, Robert
    Lissowska, Jolanta
    Peplonska, Beata
    Bardin-Mikolajczak, Alicija
    Brinton, Louise
    Gerhard, Daniela S.
    Perou, Charles
    Borresen-Dale, Anne-Lise
    Chanock, Stephen
    [J]. CANCER RESEARCH, 2006, 66 (08)
12345